Nasopharyngeal Cancer: Introduction

  • Nasopharyngeal cancer is a rare form of malignant cancer that occurs in the nasopharynx. The nasopharynx is the upper part of the pharynx (throat) behind the nose. Nasopharynx is located at the base of the skull, above the roof of the mouth. It is the opening for nostrils.

Read Report Overview - https://www.transparencymarketresearch.com/nasopharyngeal-cancer-treatment-market.html

  • Nasopharyngeal cancer commonly starts in the squamous cells that line the nasopharynx. The exact causes of nasopharyngeal cancer are not known; however, a few risk factors are associated nasopharyngeal cancer. Exposure to the Epstein-Barr virus is considered a common risk factor of nasopharyngeal cancer. People with Chinese or East Asian ancestry are also found to be more prone to the cancer.
  • Initial symptoms of nasopharyngeal cancer include lump in the nose or neck, sore throat, difficulty in breathing or speaking, nosebleed, difficulty in hearing, pain or ringing in the ear, and/or headaches

Key Drivers and Restraints of Global Nasopharyngeal Cancer Treatment Market

  • Cancer is the second-leading cause of death globally after cardiovascular diseases. Proportion of deaths caused by cancer globally increased from 12% in 1990 to 15% in 2013. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths every year.

Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78176

  • Africa, Asia, and Central and South America account for more than 60% of the new cancer cases in the world. Furthermore, 70% of deaths caused by cancer globally take place in these regions. Increase in prevalence of cancers is anticipated to drive the demand for nasopharyngeal cancer treatment during the forecast period.
  • High price of therapeutic procedures, such as surgeries, chemotherapy, and radiation therapy, results in out-of-pocket expenditure among non-insured cancer patients. High price of drugs adds to the overarching financial burden of the treatment. This can act as a barrier for the global nasopharyngeal cancer treatment market.

Chemotherapy Treatment Type Segment to Lead Global Nasopharyngeal Cancer Treatment Market

  • The global nasopharyngeal cancer treatment market can be segmented based on treatment type, end-user, and region
  • In terms of treatment type, the global nasopharyngeal cancer treatment market can be divided into radiation therapy, chemotherapy, and surgery. The radiation therapy segment can be further bifurcated into external radiation therapy and internal radiation therapy. External radiation therapy includes intensity-modulated radiation therapy (IMRT) and stereotactic radiation therapy, while internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.

Request COVID Analysis on Nasopharyngeal Cancer Treatment Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78176

  • Based on end-user, the global nasopharyngeal cancer treatment market can be divided into hospitals, clinics, and cancer treatment & rehabilitation centers

Asia Pacific to be Lucrative Region of Market

  • In terms of region, the global nasopharyngeal cancer treatment market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Prevalence of diseases, such as cancer, diabetes, and neurological disorders, has increased in Asia Pacific due to rise in geriatric population and changing lifestyles in developing economies in the region. These factors are anticipated to drive the demand for better diagnosis and prevention of cancer in the near future. In turn, this is likely to offer lucrative opportunities to companies operating in the nasopharyngeal cancer treatment market in the next few years. People of East Asian ethnicity are found to be more susceptible to nasopharyngeal cancer. This is a key factor driving the nasopharyngeal cancer treatment market in Asia.

Pre Book Nasopharyngeal Cancer Treatment Market Report –  https://www.transparencymarketresearch.com/checkout.php?rep_id=78176&ltype=S

Key Players Operating in Global Nasopharyngeal Cancer Treatment Market

Leading players operating in the global nasopharyngeal cancer treatment market are:

  • Hoffmann-La Roche AG
  • Sanofi S.A.
  • Celgene Corporation
  • Merck & Co., Inc.

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/